"Leaders bring things to conclusion, not necessarily consensus.” ? Miles Anthony Smith
Today, we take a deeper look at an interesting developmental firm that just came public a few years ago.
Company Overview:
Spring Bank Pharmaceuticals (SBPH) IPO’d in 2016 and is a Massachusetts based clinical stage biopharmaceutical company. The company is focused on developing a novel class of therapeutics using their proprietary small molecule nucleic acid hybrid chemistry platform. The therapeutics are comprised of small segments of nucleic acids that are designed to target and modulate the activity of particular proteins